S&P Biotech ETF
Global X S&P Biotech offers a great buying opportunity at $35

Global X S&P Biotech offers a great buying opportunity at $35
Cleanaway Waste Management is under Algo Engine buy conditions. We’re accumulating the stock in our investor portfolio within the $2 – $2.35 price range.
Vanguard MSCI International Small Companies Index is trading 15% below the pre covid highs.
Woolworths, one of Australia’s leading retail companies, has reported an impressive 5.3% increase in total sales for the first quarter of the fiscal year 2024. With a total revenue of $17.2 billion, Woolworths continues to demonstrate its robust performance in the market. Additionally, investors will be pleased to know that the forward dividend yield for FY24 stands at a promising 3.2%. This is a testament to Woolworths’ commitment to delivering value to its shareholders. As the company continues to thrive and expand its offerings, customers can expect an even better shopping experience at Woolworths stores across the country. Whether it’s grocery shopping or exploring various departments, Woolworths remains dedicated to providing quality
Woolworths Group 1Q24 total sales increased 5.3% to $17.2bn. The forward dividend yield into FY24 is now 3.2%.
VanEck Vectors Global Health Leaders is nearing support and we expect buying interest to build at $9.90
Global X ROBO Global Robotics & Automation within the $60 – $65 range moves to an “accumulate” rating.
Global X Copper Miners is rated “accumulate” and we see value within the $10 to $10.50 price range.
VanEck Vectors China New Economy has increasing buying interest at $6.45
Sorry, but this content is restricted to our members.
Please login with your account or register for a free trial. If your trial has expired, then you may renew it here.
If you are having an issue with your account, then please get in touch with us.
BlueScope Steel has cut 1H24 EBIT guidance to A$620-670m. We’re buyers within the $15 – $17 price range and expect earnings to recover in 2025.
Or start a free thirty day trial for our full service, which includes our ASX Research.